TC-LasVegas said...
Again the issue is over diagnosing an illness that would otherwise never be a threat or ever cause any issues and then when diagnosed treating a cancer that was not life threatening and could have been left untreated.
But as we continue to see, the fact that we are good at identifying prostate cancer that needs treatment, we are not so good at diagnosing prostate cancer that is not or will ever be a threat. So the norm today is to "err on the side" of morbid and invasive radical therapies. Even though the error rate is extremely high ~ higher than just about all other cancers.
Tony
I don't disagree that ODOT is a problem, but, as Tony points out, if you cannot GUARANTEE my PCa won't cause me significant harm in my expected lifetime, you'll get a fight from me about
treatment. Life threatening and life altering aren't the same thing, IMO. Perhaps I'll outlive metastatic PCa, perhaps I won't. Write me a guarantee to that effect, and I might have reconsidered. Tell your brothers with positive bx results the same thing.
There is no
cookie-cutter approach to this. I don't think anybody here suggests that.
However, there is significant danger when we try to go the other way. Read the Medscape article about
a study from the Swedes about
inappropriate over-scanning.
www.medscape.com medscape said...
. . . .
The results were interesting. They showed that over time there was a reduction from 43% to 3% in the number of men with low-risk disease (a Gleason score of 6 or lower, prostate-specific antigen level < 10 ng/mL, and clinical T1 disease) who received an inappropriate scan. This implementation had a positive effect in lowering the misuse of tests. Unfortunately, there was also about a 15% drop in the proper use of scanning for men with high-risk disease, and it is unclear why that occurred.
. . .
Let's just toss those 15% out in the cold and say, "sorry."
Hyperbolic? Perhaps. Give some clinicians an out and they'll take it, especially when cost savings pressures are involved. There has to be a happy medium here somewhere.